STOCK TITAN

Kazia Therapeutics (KZIA) EPS by Year

KZIA NASDAQ

Kazia Therapeutics Limited lost $0.02 per diluted share in fiscal year 2025. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Kazia Therapeutics Limited has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.02
Source SEC Filings (20-F/6-K) Latest period Q2 FY2026, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KZIA EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
EPS (Diluted)-$0.02-$0.07n/m-$0.07n/m-$0.13n/m-$0.05-$0.12-$12.52n/m-$9.23-$1.75n/m-$2.10

KZIA EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'266-KQ4'256-KQ2'256-KQ4'2420-FQ2'246-KQ4'2320-FQ2'236-KQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
EPS (Diluted)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Kazia Therapeutics Limited financials

Frequently Asked Questions

Kazia Therapeutics Limited lost $0.02 per diluted share in fiscal year 2025.

Across the 10 fiscal years this page covers, Kazia Therapeutics Limited (KZIA) diluted earnings per share went from -$2.10 in fiscal year 2016 to -$0.02 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Kazia Therapeutics Limited (KZIA) reported on that line in every period on record.